Lozada, Reynaldo T.
HRN: 11-63-02 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/26/2025
CIPROFLOXACIN 500MG (TAB)
11/26/2025
12/03/2025
PO
500mg/tab
BID
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes